- Q1 2024 Mind Medicine (MindMed) Inc Earnings Call TranscriptMay 08, 2024€9.94Earnings
- Q4 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptFeb 28, 2024€4.89 (+1.45%)Earnings
- Mind Medicine (MindMed) Inc to Host Conference Call TranscriptDec 14, 2023
- Q3 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptNov 02, 2023€2.52 (+8.91%)Earnings
- Mind Medicine (MindMed) Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 28, 2023
- Q2 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptAug 03, 2023€4.26 (-3.22%)Earnings
- Mind Medicine (MindMed) Inc at H.C. Wainwright Neuropsychiatry Virtual Conference TranscriptJun 26, 2023
- Mind Medicine (MindMed) Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Mind Medicine (MindMed) Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Q1 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptMay 04, 2023€3.24 (-2.59%)Earnings
- Mind Medicine (MindMed) Inc at ROTH Conference TranscriptMar 13, 2023
- Mind Medicine (MindMed) Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Q4 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptMar 09, 2023€3.1 (-1.59%)Earnings
- Mind Medicine (MindMed) Inc at Cowen Health Care Conference TranscriptMar 08, 2023
- Mind Medicine (MindMed) Inc at Jefferies London Healthcare Conference TranscriptNov 16, 2022
- Q3 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptNov 10, 2022€2.43 (-2.80%)Earnings
- Q2 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptAug 11, 2022€9.51 (+3.09%)Earnings
- Mind Medicine (MindMed) Inc at Canaccord Genuity Growth Conference TranscriptAug 10, 2022
- Mind Medicine (MindMed) Inc at Jefferies Healthcare Conference TranscriptJun 10, 2022
- Q1 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptMay 16, 2022€11.84 (+6.96%)Earnings
- Q4 2021 Mind Medicine (MindMed) Inc Earnings Call TranscriptMar 28, 2022€16.13 (-0.42%)Earnings
- Q2 2021 Mind Medicine (MindMed) Inc Earnings Call TranscriptAug 16, 2021Earnings
Mind Medicine (MindMed) Inc at H.C. Wainwright Neuropsychiatry Virtual Conference Transcript
Hello, everyone, and welcome to the fourth annual H.C. Wainwright Neuropsychiatry Virtual Conference. My name is Patrick Trucchio. I'm a senior healthcare analyst at H.C. Wainwright and the host for the conference today. We have a robust agenda for the conference this year with more than 20 companies presenting with their sessions available on demand through the conference portal. In addition, we're expecting a full day of panels and fireside chats on the day of the conference, June 26, with a focus on novel treatments in various mood disorders, along with AI and drug development, payer and commercial considerations, among many other topics.
And with that, it's my pleasure to introduce our next presenter, Robert Barrow, CEO of Mind Medicine, a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, starting first with lead candidate MM-120 in generalized anxiety disorder and ADHD.
So maybe we could first start with just talking more about MindMed, if you could give us the history
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)